PD-137968

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePD-137968
Drug Alias NamePD-137968
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E2 synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsColitisGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParke-Davis Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWarner Lambert
Active IndicationsN/A
Inactive IndicationsColitisGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A